Loading patent…
AssigneeAbbott Molecular Inc.
InventorsOlli-P Kallioniemi, Uwe Richard Muller, Guido Sauter, Juha Kononen, Maarit Barlund
Estimating the term…
A method is disclosed for rapid molecular profiling of tissue or other cellular specimens by placing a donor specimen in an assigned location in a recipient array, providing copies of the array, and performing a different biological analysis of each copy. The results of the different biological analyses are compared to determine if there are correlations between the results of the different biological analyses at each assigned location. In some embodiments, the specimens may be tissue specimens from different tumors, which are subjected to multiple parallel molecular (including genetic and immunological) analyses. The results of the parallel analyses are then used to detect common molecular characteristic of the genetic disorder type, which can subsequently be used in the diagnosis or treatment of the disease. The biological characteristics of the tissue can be correlated with clinical or other information, to detect characteristics associated with the tissue.
A composition suitable for detecting the presence of cancerous cells in a human breast tissue specimen, said composition comprising nucleic acids, wherein said nucleic acids consist of (i) a labeled probe suitable for detecting expression of PDGF-β, said probe obtained by PCR screening of a human genomic library and suitable for detecting expression of PDGF- βin the human breast cancer specimen;
A composition suitable for detecting the presence of cancerous cells in a human breast tissue specimen, said composition comprising nucleic acids, wherein said nucleic acids consist of (i) a labeled probe suitable for detecting expression of PDGF-β, said probe obtained by PCR screening of a human genomic library and suitable for detecting expression of PDGF-βin the human breast cancer specimen;
A composition suitable for detecting the presence of cancerous cells in a human breast tissue specimen, said composition comprising nucleic acids, wherein said nucleic acids consist of (i) a labeled probe suitable for detecting expression of PDGF-β, said probe obtained by PCR screening of a human genomic library and suitable for detecting expression of PDGF-βin the human breast cancer specimen;
Dependencies are inferred from the claim text.